Naughty Flicks

Skip NavigationMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting ClubPROLivestreamMenuHere are some of the companies making headlines in midday trading. Tyson Foods — The food company tumbled nearly 7% after slashing full-year guidance, citing beef pressures. Tyson now expects fiscal 2026 adjusted operating income of $1.85 billion to $2.05 billion, down from a prior $2.1 billion to $2.3 billion. Full-year revenue growth is pegged at 1.5% to 2.0% compared to prior guidance of 2.5% to 3.5%. Meta Platforms — The Instagram parent rose 3% following the rollout of its artificial intelligence model Muse Spark 1.3. Dell Technologies — The maker of laptops and servers rose for a second day, climbing 5% in midday trading. Earlier this week, Dell posted quarterly results that topped estimates on the top and bottom lines and lifted its fiscal 2027 forecast. Coinbase , Strategy — Companies tied to cryptocurrency saw shares rise after bitcoin jumped more than 4% to trade above $80,000. At one point, the flagship crypto asset touched its highest level since May 15. Crypto trading platform Coinbase advanced 10% while bitcoin treasury company Strategy gained 13%. Riot Platforms added 11%. Robinhood — Shares of the trading app jumped 15% after Deutsche Bank issued a report pointing to prediction market tailwinds for brokers, asset managers and exchanges. The bank thinks company financial key performance indicator contracts could offer the strongest potential for growth in prediction markets, and sees Robinhood as a beneficiary. Ciena — The optical networking company slumped 9%. Revenue guidance for the fiscal year ending in October came in at $6.42 billion, plus or minus $50 million, compared to the FactSet consensus of $6.34 billion. The outlook overshadowed top and bottom line third-quarter results that topped Street estimates. Tesla — The electric vehicle maker advanced more than 6% ahead of the company’s Cybercab event slated for after the close. Tesla is set to launch a two-seater robotaxi at an event in Austin on Thursday evening. Shares of SpaceX, Elon Musk’s space company, also rose nearly 6% in sympathy. Snowflake — Shares surged almost 22% after second-quarter results topped analyst expectations. For the quarter, Snowflake posted adjusted earnings of 62 cents per share on revenue of $1.55 billion. Analysts surveyed by LSEG had anticipated 45 cents in earnings per share and $1.48 billion in revenue. Snowflake also raised full-year product revenue guidance. Software stocks — Snowflake lifted software peers. Datadog jumped more than 2%, while ServiceNow was up by almost 6%. Salesforce rose just over 3%. Hewlett Packard Enterprise — The enterprise technology company slipped 4%. HPE is calling for earnings growth of 16% to 20% for the fiscal year ending October 2027, while the FactSet consensus estimated a 18.7% increase. Cash flow for the period is expected reach at least $5 billion, versus the Street’s forecast for $4.79 billion. Broadcom — The chipmaker lost 3% as investors responded negatively to a fourth-quarter revenue forecast of $34.8 billion compared to a $35.03 billion consensus estimate. Fourth-quarter non-GAAP operating margin projections came in at 66%, below the 66.5% estimate. Broadcom reported revenue of $29.59 billion for the third quarter and adjusted earnings of $3.32 per share. Campbell’s Company – The food and beverage company fell 9% after earnings guidance for the fiscal year 2027 lagged expectations. Campbell’s expects earnings of between $1.65 and $1.80 per share in fiscal 2027, excluding one-time items, compared to a FactSet consensus for $1.83 per share, and forecast revenue growth to contract at a faster rate than expected. Ultragenyx Pharmaceutical – Shares plunged 44% after Ultragenyx reported that Phase 3 trial results for its drug to treat Angelman syndrome, a rare genetic neurodevelopmental disorder, did not achieve its primary endpoint. The company said it was disappointed in the result and will evaluate the program to develop the drug, and implement significant cost reductions. Moderna – Shares were off more than 4% after the vaccine maker was downgraded by Rothschild & Co Redburn to sell. Analysts said the stock, after a huge surge following the success in a trial of its experimental cancer vaccine for melanoma, is now overvalued. Argan – The engineering and construction stock rallied 4% after Argan posted better-than-expected second-quarter earnings and revenue. Argan earned $3.76 per share, above the $2.64 per share that analysts polled by FactSet had estimated. Revenue of $384 million beat analysts’ consensus forecast of $300.5 million. Victoria’s Secret – The maker of women’s intimate apparel sank more than 13% after Victoria’s Secret missed revenue estimates for the second quarter. Guidance for operating income in the current quarter missed expectations, according to analysts polled by FactSet, but the company’s forecast for full-year revenue matched estimates. Adjusted earnings for the second quarter beat expectations. Netskope – Shares of the cybersecurity company surged 12%. Netskope sees full-year revenue of $888 million to $892 million, above the LSEG consensus estimate of $881 million. Netskope forecast an adjusted loss of 15 cents a share for the period, below analysts’ consensus estimated loss of 18 cents per share. NetApp – The data infrastructure company shed 8%. NetApp forecast fiscal second-quarter non-GAAP gross margin of 67% to 68%, down from 70.6% reported for the first quarter, and second-quarter non-GAAP operating margin of 30.9% to 31.9% versus an actual 31.9% in the last quarter. Deferred revenue in the first quarter totaled $4.85 billion, short of the $4.86 billion StreetAccount consensus estimate. – CNBC’s Michelle Fox, Nick Wells, Sean Conlon and Tobias Burns contributed reporting.